CA1079637A - Cephalosporine tablets - Google Patents

Cephalosporine tablets

Info

Publication number
CA1079637A
CA1079637A CA262,741A CA262741A CA1079637A CA 1079637 A CA1079637 A CA 1079637A CA 262741 A CA262741 A CA 262741A CA 1079637 A CA1079637 A CA 1079637A
Authority
CA
Canada
Prior art keywords
weight
tablet according
tablet
orally active
disintegrant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA262,741A
Other languages
English (en)
French (fr)
Inventor
Richard Marsden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Application granted granted Critical
Publication of CA1079637A publication Critical patent/CA1079637A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA262,741A 1975-10-11 1976-10-05 Cephalosporine tablets Expired CA1079637A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB41744/75A GB1560475A (en) 1975-10-11 1975-10-11 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
CA1079637A true CA1079637A (en) 1980-06-17

Family

ID=10421183

Family Applications (1)

Application Number Title Priority Date Filing Date
CA262,741A Expired CA1079637A (en) 1975-10-11 1976-10-05 Cephalosporine tablets

Country Status (6)

Country Link
JP (1) JPS5247914A (de)
AT (1) AT348670B (de)
AU (1) AU514174B2 (de)
CA (1) CA1079637A (de)
DD (1) DD126926A5 (de)
GB (1) GB1560475A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE13486T1 (de) * 1980-11-12 1985-06-15 Ciba Geigy Ag Schnellzerfallende arzneimittel-presslinge.
JPS59155310A (ja) * 1983-02-21 1984-09-04 Daicel Chem Ind Ltd 崩壊性の改良された固型薬剤の製造方法
JPS59167522A (ja) * 1983-03-14 1984-09-21 Daicel Chem Ind Ltd 固型薬剤の製造法
JPS59176217A (ja) * 1983-03-28 1984-10-05 Daicel Chem Ind Ltd 固形薬剤用粉粒体組成物
JPS59193815A (ja) * 1983-04-15 1984-11-02 Daicel Chem Ind Ltd 錠剤の製法
JPS62173183A (ja) * 1986-01-25 1987-07-30 マツダ株式会社 組立搬送治具への物品取付け方法
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug

Also Published As

Publication number Publication date
GB1560475A (en) 1980-02-06
AT348670B (de) 1979-02-26
JPS619283B2 (de) 1986-03-22
DD126926A5 (de) 1977-08-24
AU1829276A (en) 1978-04-06
JPS5247914A (en) 1977-04-16
ATA749476A (de) 1978-07-15
AU514174B2 (en) 1981-01-29

Similar Documents

Publication Publication Date Title
US4143129A (en) Cephalexin tablets
EP0223590B1 (de) Hydroxypropylcelluloseether enthaltende Mittel mit verzögerter Wirkstoffabgabe
KR100468204B1 (ko) 베타-락탐화합물을함유하는응집체
US4950484A (en) Pharmaceutical tablet, pharmaceutical granulate and process for their preparation
US5286492A (en) Method of treatment of Heliobacter pylori infections with triclosan
FI110354B (fi) Menetelmä farmaseuttisten rakeiden valmistamiseksi
CZ295893B6 (cs) Granulát a rychle se rozvolňující a rychle rozpustná kompozice
US3453360A (en) Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
US3865935A (en) Tableting of erythromycin base
CA1079637A (en) Cephalosporine tablets
RU2150276C1 (ru) Фармацевтическая препаративная форма цефаклора и способ ее получения
JP2901635B2 (ja) アルギネートとポリアクリレートの混合物及びその使用
AU2002224011B2 (en) A pharmaceutical composition for controlled release of a beta-lactam antibiotic
JPH08310969A (ja) 固形薬品組成物及びその製造方法
AU611740B2 (en) Pharmaceutical composition and process for its preparation
IE42952B1 (en) Tablet formulation
CA2280925A1 (en) Stabilized cefuroxime axetil
EP0519371B1 (de) Feste, stabilisierte Arzneimittelform von Choline-Metall-Carboxymethylzellulose-Salicylat enthaltenden Zusammensetzungen
US5547943A (en) Sucralfate preparation
KR960000429B1 (ko) 니트로푸란토인의 경구투여용 서방성/속방성 약제학적 복합 캅셀
KR910004481B1 (ko) 용출성이 개량된 제제 조성물
EP0768874A1 (de) Pharmazeutische zusammensetzungen welche triclosan oder derivate und edta oder egta enthalten
CA2052637A1 (en) Pharmaceutical preparation having an improved absorption property

Legal Events

Date Code Title Description
MKEX Expiry